PharmaJet, Nigeria’s National Primary Health Care Development Agency, and Health-focused Consortium Begin Implementation of Study Using Tropis® ID for Routine Immunization
Partners are also evaluating the acceptability and feasibility of using needle-free from the healthcare worker and caregiver perspective.
- Partners are also evaluating the acceptability and feasibility of using needle-free from the healthcare worker and caregiver perspective.
- View the full release here: https://www.businesswire.com/news/home/20231024060890/en/
Nigerian baby receiving polio vaccine with the PharmaJet Tropis® Precision Needle-free System. - Evidence from the study is intended to inform policy regarding intradermal delivery of polio vaccine in routine immunization settings.
- Study preparation included the development of standard operating procedures to ensure congruence with the country’s existing medical guidelines.